<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>hematology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>hematology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma
Authors: Parker, H.; Mirandari, A.; Jaramillo Oquendo, C.; Duran-Ferrer, M.; Stevens, B.; Buermann, L.; Amarasinghe, H. E.; Thomas, J.; Kadalayil, L.; Carr, L.; Syeda, S.; Sakthipakan, M.; Parry, M.; Davis, Z.; McIver-Brown, N.; Xochelli, A.; Ennis, S.; Scarfo, L.; Ghia, P.; Kalpadakis, C.; Pangalis, G.; Rossi, D.; Wagner, S.; Ahearne, M.; Seifert, M.; Plass, C.; Weichenhan, D.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/hematology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="hematology" />
<meta property="og:description" content="Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma
Authors: Parker, H.; Mirandari, A.; Jaramillo Oquendo, C.; Duran-Ferrer, M.; Stevens, B.; Buermann, L.; Amarasinghe, H. E.; Thomas, J.; Kadalayil, L.; Carr, L.; Syeda, S.; Sakthipakan, M.; Parry, M.; Davis, Z.; McIver-Brown, N.; Xochelli, A.; Ennis, S.; Scarfo, L.; Ghia, P.; Kalpadakis, C.; Pangalis, G.; Rossi, D.; Wagner, S.; Ahearne, M.; Seifert, M.; Plass, C.; Weichenhan, D." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/hematology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-24T10:40:04+00:00" />
<meta property="article:modified_time" content="2024-01-24T10:40:04+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="hematology"/>
<meta name="twitter:description" content="Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma
Authors: Parker, H.; Mirandari, A.; Jaramillo Oquendo, C.; Duran-Ferrer, M.; Stevens, B.; Buermann, L.; Amarasinghe, H. E.; Thomas, J.; Kadalayil, L.; Carr, L.; Syeda, S.; Sakthipakan, M.; Parry, M.; Davis, Z.; McIver-Brown, N.; Xochelli, A.; Ennis, S.; Scarfo, L.; Ghia, P.; Kalpadakis, C.; Pangalis, G.; Rossi, D.; Wagner, S.; Ahearne, M.; Seifert, M.; Plass, C.; Weichenhan, D."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "hematology",
      "item": "https://trxiv.yorks0n.com/posts/hematology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "hematology",
  "name": "hematology",
  "description": "Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma\nAuthors: Parker, H.; Mirandari, A.; Jaramillo Oquendo, C.; Duran-Ferrer, M.; Stevens, B.; Buermann, L.; Amarasinghe, H. E.; Thomas, J.; Kadalayil, L.; Carr, L.; Syeda, S.; Sakthipakan, M.; Parry, M.; Davis, Z.; McIver-Brown, N.; Xochelli, A.; Ennis, S.; Scarfo, L.; Ghia, P.; Kalpadakis, C.; Pangalis, G.; Rossi, D.; Wagner, S.; Ahearne, M.; Seifert, M.; Plass, C.; Weichenhan, D.",
  "keywords": [
    
  ],
  "articleBody": " Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma\nAuthors: Parker, H.; Mirandari, A.; Jaramillo Oquendo, C.; Duran-Ferrer, M.; Stevens, B.; Buermann, L.; Amarasinghe, H. E.; Thomas, J.; Kadalayil, L.; Carr, L.; Syeda, S.; Sakthipakan, M.; Parry, M.; Davis, Z.; McIver-Brown, N.; Xochelli, A.; Ennis, S.; Scarfo, L.; Ghia, P.; Kalpadakis, C.; Pangalis, G.; Rossi, D.; Wagner, S.; Ahearne, M.; Seifert, M.; Plass, C.; Weichenhan, D.; Kimby, E.; Sutton, L.-A.; Rosenquist, R.; Forconi, F.; Stamatopoulos, K.; Salido, M.; Ferrer, A.; Thieblemont, C.; Ljungstrom, V.; Amini, R.-M.; Oscier, D.; Walewska, R.; Rose-Zerilli, M. J.; Gibson, J.; Martin-Subero, J. I.; O\nScore: 3.5, Published: 2024-01-17 DOI: 10.1101/2024.01.16.24301320\nThe epiCMIT (epigenetically-determined Cumulative MIToses) mitotic clock traces B-cell mitotic history via DNA methylation changes in heterochromatin and H3K27me3-containing chromatin. While high scores correlated with poor outcomes in CLL and MCL, its prognostic significance in SMZL remains unknown. Derived from 142 SMZL cases using DNA methylation microarrays, epiCMIT values were correlated with genomic, transcriptomic, and clinical data. EpiCMIT as a continuous variable was significantly higher in females (p=0.02), patients with IGHV1-2*04 allele usage (p\u003c0001), intermediate IGHV somatic hypermutation load (97-99.9% identity, p=0.04), elevated mutational burden (25 vs. 17 mut/Mb, p=0.001), driver gene mutations [KLF2 (p\u003c0.001), NOTCH2 (p\u003c0.01), TP53 (p=0.01), KMT2D (p\u003c0.001)], and del(7q) (p=0.01). Negative correlation between epiCMIT and telomere length (r=-0.29 p\u003c0.001) supported the association between cumulated proliferation and telomere attrition. While univariate analysis highlighted epiCMIT as robust predictor of shorter treatment-free survival (TFS), multivariate analysis confirmed epiCMIT as an independent marker for shorter TFS. In summary, our matched multi-omic datasets facilitate the clinico-biological characterization of SMZL and introduces epiCMIT as a strong prognostic marker, identifying high-risk patients and predicting reduced treatment-free survival, hence providing a new tool for risk-adapted patient management.\n",
  "wordCount" : "293",
  "inLanguage": "en",
  "datePublished": "2024-01-24T10:40:04Z",
  "dateModified": "2024-01-24T10:40:04Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/hematology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      hematology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 24, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.16.24301320">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.16.24301320" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.16.24301320">
        <p class="paperTitle">Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.16.24301320" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.16.24301320" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Parker, H.; Mirandari, A.; Jaramillo Oquendo, C.; Duran-Ferrer, M.; Stevens, B.; Buermann, L.; Amarasinghe, H. E.; Thomas, J.; Kadalayil, L.; Carr, L.; Syeda, S.; Sakthipakan, M.; Parry, M.; Davis, Z.; McIver-Brown, N.; Xochelli, A.; Ennis, S.; Scarfo, L.; Ghia, P.; Kalpadakis, C.; Pangalis, G.; Rossi, D.; Wagner, S.; Ahearne, M.; Seifert, M.; Plass, C.; Weichenhan, D.; Kimby, E.; Sutton, L.-A.; Rosenquist, R.; Forconi, F.; Stamatopoulos, K.; Salido, M.; Ferrer, A.; Thieblemont, C.; Ljungstrom, V.; Amini, R.-M.; Oscier, D.; Walewska, R.; Rose-Zerilli, M. J.; Gibson, J.; Martin-Subero, J. I.; O</p>
        <p class="info">Score: 3.5, Published: 2024-01-17 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.16.24301320' target='https://doi.org/10.1101/2024.01.16.24301320'> 10.1101/2024.01.16.24301320</a></p>
        <p class="abstract">The epiCMIT (epigenetically-determined Cumulative MIToses) mitotic clock traces B-cell mitotic history via DNA methylation changes in heterochromatin and H3K27me3-containing chromatin. While high scores correlated with poor outcomes in CLL and MCL, its prognostic significance in SMZL remains unknown. Derived from 142 SMZL cases using DNA methylation microarrays, epiCMIT values were correlated with genomic, transcriptomic, and clinical data. EpiCMIT as a continuous variable was significantly higher in females (p=0.02), patients with IGHV1-2*04 allele usage (p&lt;0001), intermediate IGHV somatic hypermutation load (97-99.9% identity, p=0.04), elevated mutational burden (25 vs. 17 mut/Mb, p=0.001), driver gene mutations [KLF2 (p&lt;0.001), NOTCH2 (p&lt;0.01), TP53 (p=0.01), KMT2D (p&lt;0.001)], and del(7q) (p=0.01). Negative correlation between epiCMIT and telomere length (r=-0.29 p&lt;0.001) supported the association between cumulated proliferation and telomere attrition. While univariate analysis highlighted epiCMIT as robust predictor of shorter treatment-free survival (TFS), multivariate analysis confirmed epiCMIT as an independent marker for shorter TFS. In summary, our matched multi-omic datasets facilitate the clinico-biological characterization of SMZL and introduces epiCMIT as a strong prognostic marker, identifying high-risk patients and predicting reduced treatment-free survival, hence providing a new tool for risk-adapted patient management.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
